This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
|15827-60-8||DTPMP||Phosphonic acid, [[(phosphonomethyl)Imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-||HTML||Does not meet||None planned at this time|
|March 2020||Anticipated publication of the final screening assessment.|
|March 16, 2019||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 11.|
Report a problem or mistake on this page
- Date modified: